PIK3CA and neoplasm: In addition to the influence of tumor COX-2 expression on aspirin treatment benefit in CRC as detailed above, a recent study showed that only CRC patients bearing a mutation in PIK3CA (exon 9 or exon 20) benefitted from aspirin treatment, and not patients with wild-type PIK3CA tumors [192].